Parkinson

fondazione-limpe logo

Fondazione LIMPE per il Parkinson Onlus – Bando per il finanziamento della ricerca sulla malattia di Parkinson e sui Parkinsonismi condotta in Italia da giovani ricercatori

La Fondazione LIMPE per il Parkinson Onlus si prefigge di affrontare la sfida dell’impatto sociale ed economico posta dalla Malattia di Parkinson e dai parkinsonismi finanziando la ricerca scientifica.L’impegno di Fondazione LIMPE vuole rivolgersi soprattutto ai giovani per garantire un futuro nello sviluppo di competenze volte alla ricerca in questo campo. In particolare, Fondazione LIMPE […]

Fondazione LIMPE per il Parkinson Onlus – Bando per il finanziamento della ricerca sulla malattia di Parkinson e sui Parkinsonismi condotta in Italia da giovani ricercatori Leggi tutto »

Parkinson’s UK – grants for non-drug approaches

Parkinson’s UK invites pre-proposals for its non-drug approaches grants. These support research to develop non-drug approaches for Parkinson’s. The focus of the scheme is to improve quality of life for people affected by Parkinson’s in the shorter term. Projects may focus on: •speech and language, physiotherapies and occupational therapies; •approaches to managing mental health; •lifestyle

Parkinson’s UK – grants for non-drug approaches Leggi tutto »

CurePSP Foundation – Venture grants

The CurePSP Foundation invites proposals for its venture grants. These support research that helps generate an integrated picture of progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) at pre-clinical and clinical levels. Projects on the following topics are of particular interest: •molecular and cellular mechanisms that may operate also in related diseases; •translational clinical research

CurePSP Foundation – Venture grants Leggi tutto »

Pubblicato nuovo bando transnazionale per la ricerca di farmaci-bersaglio nelle malattie neurodegenerative

L’iniziativa EU Joint Programme – Neurodegenerative Disease Research (JPND) ha lanciato un bando transnazionale per l’analisi su larga scala dei dati OMICS per la ricerca di farmaci-bersaglio nelle malattie neurodegenerative. Le malattie neurodegenerative sono condizioni debilitanti e in gran parte non curabili, fortemente legate all’età. I trattamenti esistenti per le malattie neurodegenerative sono limitati e riguardano principalmente i sintomi piuttosto

Pubblicato nuovo bando transnazionale per la ricerca di farmaci-bersaglio nelle malattie neurodegenerative Leggi tutto »

Team Bellucci

Team coordinato dalla Prof.ssa Bellucci vince un finanziamento promosso dall’Università di Milano e dalla Fondazione UNIMI

Il Gruppo di Ricerca coordinato dalla Prof.ssa Arianna Bellucci, afferente al Dipartimento di Medicina Molecolare e Traslazionale, è risultato vincitore di un Finanziamento nell’ambito del Bando Seed4Innovation, lo Scouting Program dell’Università Milano e di Fondazione UNIMI per il potenziamento dello Sviluppo Industriale di progetti di ricerca. Il progetto presentato, dal titolo “StoPD – Synaptic Targeting

Team coordinato dalla Prof.ssa Bellucci vince un finanziamento promosso dall’Università di Milano e dalla Fondazione UNIMI Leggi tutto »

Parkinson’s Foundation – Institutional movement disorder fellowship

The Parkinson’s Foundation, under its institutional movement disorder fellowship programme, invites applications for its research centres of excellence funding opportunity. This supports innovative team science at institutions working on a thematic area of Parkinson’s disease. Proposals must tackle critical issues or problems that are impeding progress in the field of Parkinson’s disease research. Preference will

Parkinson’s Foundation – Institutional movement disorder fellowship Leggi tutto »

Michael J Fox Foundation for Parkinson’s Research – Alpha-synuclein seed amplification assay programme

The Michael J Fox Foundation for Parkinson’s Research invites applications for its alpha-synuclein seed amplification assay programme. This supports research that will facilitate integration of alpha-synuclein seed amplification assays into clinical studies for the purposes of predicting prognosis, tracking disease progression and monitoring therapeutic response. Applicants are encouraged to submit proposals that address one or

Michael J Fox Foundation for Parkinson’s Research – Alpha-synuclein seed amplification assay programme Leggi tutto »

The Michael J.Fox Foundation for Parkinson’s Research – Bando Target Advancement Program

The Target Advancement Program is open to industry and academic investigators proposing to build conclusive evidence to rationalize biological targets and pathways for Parkinson’s disease (PD) therapeutic development. Part of our Edmond J. Safra Core Programs for PD Research, this program will support projects focused on validating targets and defining pathways implicated in PD pathological processes

The Michael J.Fox Foundation for Parkinson’s Research – Bando Target Advancement Program Leggi tutto »

The Michael J.Fox Foundation for Parkinson’s Research – Bando Parkinson’s Pathway Biomarkers

Currently, many efforts are focusing on understanding the role of various cellular processes/pathways in PD and uncovering novel targets within these pathways for therapeutic development. As such, sensitive biomarker readouts for these pathways will be critical for bridging the gap from basic to translational research and clinical trials. The Parkinson’s Pathway Biomarkers program is open

The Michael J.Fox Foundation for Parkinson’s Research – Bando Parkinson’s Pathway Biomarkers Leggi tutto »

The Michael J.Fox Foundation for Parkinson’s Research – Therapeutic Pipeline Program

The Therapeutic Pipeline Program is open to industry and academic investigators proposing novel approaches or repositioning approved or clinically safe therapies from other disease indications. Part of our Edmond J. Safra Core Programs for PD Research, the Therapeutic Pipeline Program advances Parkinson’s disease therapeutic and intervention development along the pre-clinical and clinical path. Applications should focus on studies

The Michael J.Fox Foundation for Parkinson’s Research – Therapeutic Pipeline Program Leggi tutto »

Torna in alto